Cargando…
Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
The mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway is widely activated by a variety of extracellular stimuli, and its dysregulation is associated with the proliferation, invasion, and migration of cancer cells. ERK1/2 is located at the di...
Autores principales: | Pan, Xiaoli, Pei, Junping, Wang, Aoxue, Shuai, Wen, Feng, Lu, Bu, Faqian, Zhu, Yumeng, Zhang, Lan, Wang, Guan, Ouyang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136582/ https://www.ncbi.nlm.nih.gov/pubmed/35646548 http://dx.doi.org/10.1016/j.apsb.2021.12.022 |
Ejemplares similares
-
Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy
por: Wang, Guan, et al.
Publicado: (2023) -
Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: be careful what you wish for…
por: Cook, Simon J., et al.
Publicado: (2020) -
Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
por: Jiang, Tingting, et al.
Publicado: (2021) -
Extracellular and intracellular small-molecule galectin-3 inhibitors
por: Stegmayr, John, et al.
Publicado: (2019) -
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
por: Zhang, Kai, et al.
Publicado: (2021)